FDA FY 2003 Annual Financial Report

U.S. Department of Health and Human Services

Food and Drug Administration
Annual Financial Report
Fiscal Year 2003

Table of Contents

Message from the Commissioner

Message from Chief Financial Officer

Preface

 

Section I -- Management Discussion and Analysis

Agency Overview

Program Management

Operational Effectiveness

Fiscal Responsibility

 

Section II -- Consolidated Principal Financial Statements

Consolidated Balance Sheets

Consolidated Statements of Net Costs

Consolidated Statements of Changes in Net Position

Consolidated Statements of Financing

Combined Statements of Budgetary Resources

Notes to Consolidated Principal Financial Statements

 

Section III -- Required Supplementary Information (Unaudited)

Combining Statements of Budgetary Resources
FY 2002 and FY 2003

Supplemental Consolidating Statements of Net Costs by Expense Type and Program
FY 2002 and FY 2003

Deferred Maintenance

Intra-governmental Transactions - Intra-governmental Assets

Intra-governmental Transactions - Intra-governmental Liabilities

Intra-governmental Transactions - Intra-governmental Revenues and Expenses

 

Section IV -- Required Supplementary Stewardship Information (Unaudited)

Research and Development

 

Section V -- Reports on the Audit of FDA's FY 2002 Financial Statements

Office of Inspector General's Transmittal Letter - PDF
Independent Auditors - Report on Consolidated Financial Statements
Independent Auditors - Report on Internal Control over Financial Reporting
Independent Auditors - Report on Compliance with Laws and Regulations
Agency's Response to Independent Auditors' Report - PDF
Appendix

FDA Acronyms